These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8051293)

  • 1. Two cases of acute anti-GM1 antibody elevations in response to exogenous GM1 without neurological symptoms.
    Ala TA; Perfetti PA; Frey WH
    J Neuroimmunol; 1994 Aug; 53(1):109-13. PubMed ID: 8051293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
    Uetz-von Allmen E; Sturzenegger M; Rieben R; Rihs F; Frauenfelder A; Nydegger UE
    Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
    Niebroj-Dobosz I; Janik P; Kwieciński H
    Eur J Neurol; 2004 Jan; 11(1):13-6. PubMed ID: 14692882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELISA-type titertray assay of IgM anti-GM1 autoantibodies.
    Bech E; Jakobsen J; Orntoft TF
    Clin Chem; 1994 Jul; 40(7 Pt 1):1331-4. PubMed ID: 8013109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of anti-GM1 IgM antibodies.
    Nobile-Orazio E; Carpo M; Scarlato G
    Acta Neurol (Napoli); 1991 Dec; 13(6):514-9. PubMed ID: 1805551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of testing for anti-GM1 antibodies.
    McCombe PA; Wilson R; Prentice RL
    J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.
    Pestronk A; Choksi R; Blume G; Lopate G
    Neurology; 1997 Apr; 48(4):1104-6. PubMed ID: 9109910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro.
    Heidenreich F; Leifeld L; Jovin T
    J Neuroimmunol; 1994 Jan; 49(1-2):97-108. PubMed ID: 8294565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants.
    Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP
    Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells.
    Quattrini A; Lorenzetti I; Sciorati C; Corbo M; Previtali SC; Feltri ML; Canal N; Wrabetz L; Nemni R; Clementi E
    J Neuroimmunol; 2001 Mar; 114(1-2):213-9. PubMed ID: 11240034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-GM1 and anti-GD1a antibodies in patients with motor neuron disease.
    Voumvourakis C; Rombos A; Konstantoulakis MM; Segditsa I; Papageorgiou C
    Acta Neurol Scand; 1992 Dec; 86(6):599-602. PubMed ID: 1481647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited.
    Yuki N; Yanaka C; Sudo M; Funakoshi M; Ishida H; Mori M; Kanda F; Hirata K
    J Neuroimmunol; 2014 Jul; 272(1-2):62-6. PubMed ID: 24841627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-GM1 antibodies in polyneuropathies of unknown origin.
    Finsterer J; Muellbacher W; Halbmayer WM; Fischer M; Mamoli B
    J Clin Pathol; 1996 May; 49(5):422-5. PubMed ID: 8707962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ganglioside antibodies in peripheral neuropathy.
    McCombe PA; Wilson R; Prentice RL
    Clin Exp Neurol; 1992; 29():182-8. PubMed ID: 1343861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-fucosyl-GM1 ganglioside IgG and IgM autoantibodies in human serum: no link to pathology.
    Adler G; Pacuszka T; Strugalska M; Targońska I; Panasiewicz M; Lewartowska A
    Immunol Lett; 1996 Sep; 52(2-3):89-93. PubMed ID: 8905401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls.
    Bansal AS; Abdul-Karim B; Malik RA; Goulding P; Pumphrey RS; Boulton AJ; Holt PL; Wilson PB
    J Clin Pathol; 1994 Apr; 47(4):300-2. PubMed ID: 8027366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations].
    Alpa M; Ferrero B; Cavallo R; Naretto C; Gennaro M; Bellizia L; Sena LM; Roccatello D
    G Ital Nefrol; 2002; 19(6):617-21. PubMed ID: 12508165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease.
    Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N
    J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.